Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1998 Feb;106(2):85–92. doi: 10.1289/ehp.9810685

Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study.

Y C Kao 1, C Zhou 1, M Sherman 1, C A Laughton 1, S Chen 1
PMCID: PMC1533021  PMID: 9435150

Abstract

Flavone and isoflavone phytoestrogens are plant chemicals and are known to be competitive inhibitors of cytochrome P450 aromatase with respect to the androgen substrate. Aromatase is the enzyme that converts androgen to estrogen; therefore, these plant chemicals are thought to be capable of modifying the estrogen level in women. In this study, the inhibition profiles of four flavones [chrysin (5, 7-dihydroxyflavone), 7,8-dihydroxyflavone, baicalein (5,6,7-trihydroxyflavone), and galangin (3,5,7-trihydroxyflavone)], two isoflavones [genistein (4,5,7-trihydroxyisoflavone) and biochanin A (5,7-dihydroxy-4-methoxyisoflavone)], one flavanone [naringenin (4, 5,7-trihydroxyflavanone)], and one naphthoflavone (alpha-naphthoflavone) on the wild-type and six human aromatase mutants (I133Y, P308F, D309A, T310S, I395F, and I474Y) were determined. In combination with computer modeling, the binding characteristics and the structure requirement for flavone and isoflavone phytoestrogens to inhibit human aromatase were obtained. These compounds were found to bind to the active site of aromatase in an orientation in which rings A and C mimic rings D and C of the androgen substrate, respectively. This study also provides a molecular basis as to why isoflavones are significantly poorer inhibitors of aromatase than flavones.

Full text

PDF
85

Images in this article

85Figure 1
on p.85
87Figure 2
on p.87
88Figure 3
on p.88
89Figure 4
on p.89
89Figure 5
on p.89
90Figure 6
on p.90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz C. H., Goldin B. R., Gorbach S. L., Höckerstedt K. A., Watanabe S., Hämäläinen E. K., Markkanen M. H., Mäkelä T. H., Wähälä K. T., Adlercreutz T. Soybean phytoestrogen intake and cancer risk. J Nutr. 1995 Mar;125(3 Suppl):757S–770S. doi: 10.1093/jn/125.3_Suppl.757S. [DOI] [PubMed] [Google Scholar]
  2. Adlercreutz H., Bannwart C., Wähälä K., Mäkelä T., Brunow G., Hase T., Arosemena P. J., Kellis J. T., Jr, Vickery L. E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol. 1993 Feb;44(2):147–153. doi: 10.1016/0960-0760(93)90022-o. [DOI] [PubMed] [Google Scholar]
  3. Adlercreutz H., Fotsis T., Lampe J., Wähälä K., Mäkelä T., Brunow G., Hase T. Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest Suppl. 1993;215:5–18. doi: 10.3109/00365519309090693. [DOI] [PubMed] [Google Scholar]
  4. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr. 1995 Mar;125(3 Suppl):777S–783S. doi: 10.1093/jn/125.3_Suppl.777S. [DOI] [PubMed] [Google Scholar]
  5. Bates S. E., Davidson N. E., Valverius E. M., Freter C. E., Dickson R. B., Tam J. P., Kudlow J. E., Lippman M. E., Salomon D. S. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol Endocrinol. 1988 Jun;2(6):543–555. doi: 10.1210/mend-2-6-543. [DOI] [PubMed] [Google Scholar]
  6. Block G., Patterson B., Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18(1):1–29. doi: 10.1080/01635589209514201. [DOI] [PubMed] [Google Scholar]
  7. CHENG E., STORY C. D., YODER L., HALE W. H., BURROUGHS W. Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science. 1953 Aug 7;118(3058):164–165. doi: 10.1126/science.118.3058.164. [DOI] [PubMed] [Google Scholar]
  8. Campbell D. R., Kurzer M. S. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol. 1993 Sep;46(3):381–388. doi: 10.1016/0960-0760(93)90228-o. [DOI] [PubMed] [Google Scholar]
  9. Chen S., Deng P. S., Swiderek K., Li M., Chan S. I. Interaction of flavones and their bromoacetyl derivatives with NAD(P)H:quinone acceptor oxidoreductase. Mol Pharmacol. 1995 Feb;47(2):419–424. [PubMed] [Google Scholar]
  10. Chen S., Zhou D. Functional domains of aromatase cytochrome P450 inferred from comparative analyses of amino acid sequences and substantiated by site-directed mutagenesis experiments. J Biol Chem. 1992 Nov 5;267(31):22587–22594. [PubMed] [Google Scholar]
  11. Chen S., Zhou D., Swiderek K. M., Kadohama N., Osawa Y., Hall P. F. Structure-function studies of human aromatase. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):347–356. doi: 10.1016/0960-0760(93)90238-r. [DOI] [PubMed] [Google Scholar]
  12. Collins B. M., McLachlan J. A., Arnold S. F. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids. 1997 Apr;62(4):365–372. doi: 10.1016/s0039-128x(96)00246-2. [DOI] [PubMed] [Google Scholar]
  13. Cupp-Vickery J. R., Poulos T. L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol. 1995 Feb;2(2):144–153. doi: 10.1038/nsb0295-144. [DOI] [PubMed] [Google Scholar]
  14. Das A., Wang J. H., Lien E. J. Carcinogenicity, mutagenicity and cancer preventing activities of flavonoids: a structure-system-activity relationship (SSAR) analysis. Prog Drug Res. 1994;42:133–166. doi: 10.1007/978-3-0348-7153-2_5. [DOI] [PubMed] [Google Scholar]
  15. Graham-Lorence S., Amarneh B., White R. E., Peterson J. A., Simpson E. R. A three-dimensional model of aromatase cytochrome P450. Protein Sci. 1995 Jun;4(6):1065–1080. doi: 10.1002/pro.5560040605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gunning P., Leavitt J., Muscat G., Ng S. Y., Kedes L. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4831–4835. doi: 10.1073/pnas.84.14.4831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hasemann C. A., Ravichandran K. G., Peterson J. A., Deisenhofer J. Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol. 1994 Mar 4;236(4):1169–1185. doi: 10.1016/0022-2836(94)90019-1. [DOI] [PubMed] [Google Scholar]
  18. Henderson M. Current approaches to breast cancer prevention. Science. 1993 Jan 29;259(5095):630–631. doi: 10.1126/science.8430311. [DOI] [PubMed] [Google Scholar]
  19. Howe G. R., Hirohata T., Hislop T. G., Iscovich J. M., Yuan J. M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561–569. doi: 10.1093/jnci/82.7.561. [DOI] [PubMed] [Google Scholar]
  20. Ibrahim A. R., Abul-Hajj Y. J. Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol. 1990 Oct;37(2):257–260. doi: 10.1016/0960-0760(90)90335-i. [DOI] [PubMed] [Google Scholar]
  21. Kadohama N., Yarborough C., Zhou D., Chen S., Osawa Y. Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors. J Steroid Biochem Mol Biol. 1992 Dec;43(7):693–701. doi: 10.1016/0960-0760(92)90295-t. [DOI] [PubMed] [Google Scholar]
  22. Kadohama N., Zhou D., Chen S., Osawa Y. Catalytic efficiency of expressed aromatase following site-directed mutagenesis. Biochim Biophys Acta. 1993 May 13;1163(2):195–200. doi: 10.1016/0167-4838(93)90181-p. [DOI] [PubMed] [Google Scholar]
  23. Kagawa Y. Impact of Westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev Med. 1978 Jun;7(2):205–217. doi: 10.1016/0091-7435(78)90246-3. [DOI] [PubMed] [Google Scholar]
  24. Kaldas R. S., Hughes C. L., Jr Reproductive and general metabolic effects of phytoestrogens in mammals. Reprod Toxicol. 1989;3(2):81–89. doi: 10.1016/0890-6238(89)90042-7. [DOI] [PubMed] [Google Scholar]
  25. Kao Y. C., Cam L. L., Laughton C. A., Zhou D., Chen S. Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. Cancer Res. 1996 Aug 1;56(15):3451–3460. [PubMed] [Google Scholar]
  26. Kellis J. T., Jr, Vickery L. E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science. 1984 Sep 7;225(4666):1032–1034. doi: 10.1126/science.6474163. [DOI] [PubMed] [Google Scholar]
  27. Laughton C. A., Zvelebil M. J., Neidle S. A detailed molecular model for human aromatase. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):399–407. doi: 10.1016/0960-0760(93)90243-p. [DOI] [PubMed] [Google Scholar]
  28. Lippman M. E., Dickson R. B., Kasid A., Gelmann E., Davidson N., McManaway M., Huff K., Bronzert D., Bates S., Swain S. Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem. 1986 Jan;24(1):147–154. doi: 10.1016/0022-4731(86)90044-0. [DOI] [PubMed] [Google Scholar]
  29. Liu X. F., Liu M. L., Iyanagi T., Legesse K., Lee T. D., Chen S. A. Inhibition of rat liver NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by flavonoids isolated from the Chinese herb scutellariae radix (Huang Qin). Mol Pharmacol. 1990 Jun;37(6):911–915. [PubMed] [Google Scholar]
  30. London S., Willett W. Diet and the risk of breast cancer. Hematol Oncol Clin North Am. 1989 Dec;3(4):559–576. [PubMed] [Google Scholar]
  31. Martin P. M., Horwitz K. B., Ryan D. S., McGuire W. L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978 Nov;103(5):1860–1867. doi: 10.1210/endo-103-5-1860. [DOI] [PubMed] [Google Scholar]
  32. Medina J. H., Paladini A. C., Wolfman C., Levi de Stein M., Calvo D., Diaz L. E., Peña C. Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem Pharmacol. 1990 Nov 15;40(10):2227–2231. doi: 10.1016/0006-2952(90)90716-x. [DOI] [PubMed] [Google Scholar]
  33. Poulos T. L., Finzel B. C., Gunsalus I. C., Wagner G. C., Kraut J. The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem. 1985 Dec 25;260(30):16122–16130. [PubMed] [Google Scholar]
  34. Ravichandran K. G., Boddupalli S. S., Hasermann C. A., Peterson J. A., Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science. 1993 Aug 6;261(5122):731–736. doi: 10.1126/science.8342039. [DOI] [PubMed] [Google Scholar]
  35. Santner S. J., Chen S., Zhou D., Korsunsky Z., Martel J., Santen R. J. Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):611–616. doi: 10.1016/0960-0760(93)90267-z. [DOI] [PubMed] [Google Scholar]
  36. Tekmal R. R., Ramachandra N., Gubba S., Durgam V. R., Mantione J., Toda K., Shizuta Y., Dillehay D. L. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Res. 1996 Jul 15;56(14):3180–3185. [PubMed] [Google Scholar]
  37. Wang C., Mäkelä T., Hase T., Adlercreutz H., Kurzer M. S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):205–212. doi: 10.1016/0960-0760(94)90030-2. [DOI] [PubMed] [Google Scholar]
  38. Yue W., Zhou D., Chen S., Brodie A. A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Res. 1994 Oct 1;54(19):5092–5095. [PubMed] [Google Scholar]
  39. Zhou D. J., Korzekwa K. R., Poulos T., Chen S. A. A site-directed mutagenesis study of human placental aromatase. J Biol Chem. 1992 Jan 15;267(2):762–768. [PubMed] [Google Scholar]
  40. Zhou D. J., Pompon D., Chen S. A. Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res. 1990 Nov 1;50(21):6949–6954. [PubMed] [Google Scholar]
  41. Zhou D. J., Pompon D., Chen S. A. Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308----Phe, Tyr-361----Phe, Tyr-361----Leu, and Phe-406----Arg. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):410–414. doi: 10.1073/pnas.88.2.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zhou D., Cam L. L., Laughton C. A., Korzekwa K. R., Chen S. Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450. J Biol Chem. 1994 Jul 29;269(30):19501–19508. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES